• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Amryt Pharma plc - American Depositary Shares (NQ: AMYT )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, Apr 11, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open -
    Bid (Size) 14.63 (8)
    Ask (Size) 14.90 (1)
    Prev. Close 14.70
    Today's Range N/A - N/A
    52wk Range N/A - N/A
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc
    From Amryt Pharma plc
    Via GlobeNewswire
    High Court of Justice of England and Wales Sanctions Scheme of Arrangement
    From Amryt Pharma plc
    Via GlobeNewswire

    Performance

    More News

    Read More
    Amryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici
    From Amryt Pharma plc
    Via GlobeNewswire
    Top 5 Health Care Stocks That Are Ticking Portfolio Bombs
    Via Benzinga
    AMYT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Amryt Pharma Plc Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    Why Shares of Amryt Pharma Jumped This Week
    Via The Motley Fool
    AMRYT PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amryt Pharma Plc - AMYT
    From Kahn Swick & Foti, LLC
    Via Business Wire
    AMRYT PUBLISHES SCHEME CIRCULAR AND ANNOUNCES THE SHAREHOLDER MEETINGS TO CONSIDER AND VOTE ON THE CHIESI ACQUISITION WILL BE HELD ON MARCH 22, 2023
    From Amryt Pharma plc
    Via GlobeNewswire
    AMRYT PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amryt Pharma Plc - AMYT
    From Kahn Swick & Foti, LLC
    Via Business Wire
    Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023
    Via Benzinga
    S&P 500 Gains 0.6%; Albireo Pharma Shares Spike Higher
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For January 10, 2023
    Via Benzinga
    Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Nasdaq Surges Over 200 Points; Crude Oil Rises 2%
    Via Benzinga
    Tesla, Zillow, Albireo Pharma And Some Other Big Stocks Moving Higher On Monday
    Via Benzinga
    US Stocks Open Higher; Dow Rises 150 Points
    Via Benzinga
    AMYT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Amryt Pharma Plc Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    Benzinga's Top Ratings Upgrades, Downgrades For January 9, 2023
    Via Benzinga
    Adobe To Rally 25%? Here Are 10 Other Analyst Forecasts For Monday
    Via Benzinga
    Italian Privately Held Chiesi Farmaceutici To Acquire Amryt Pharma For $1.25B
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Why CinCor Pharma Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc
    From Amryt Pharma plc
    Via GlobeNewswire
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.